FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/23/2026
Back to search
Official data from USPTO
LIPOMED
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
LIPOMED
ST13
US500000079392576Class
1, 5, 42
Filing
79392576
Registration
8081491
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
07/23/2026
Trademark type
Word
Nice classes
1, 5, 42
Filing date
01/12/2024
Registration date
12/30/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/30/2025
Last transaction
07/23/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
GB
Examiner
O'BRIEN, JENNIFER LYNN
Law office
N30
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
LGC Limited
Representatives
Matthew Frisbee Leason Ellis LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals used in industryscienceagriculturehorticulture and forestryexcept fungicidesherbicidesinsecticidesparasiticides; chemicals and chemical productschemical reagentsassaysbuffer and standard solutions used in analytical chemistryanalytesmulti-analytes and multi-analyte mixturesfor use in research; chemical reagents for use with chemicals and agrochemicalsother than for medical or veterinary purposes; substances for analytical and biochemical sciencegenetic measurementschemical diagnosticsforensic analysisDNA testing and analytical molecular biologychemical reagentsresearch assayschemical substances for use in scientific researchother than for medical or veterinary purposes in the nature of analytesmulti-analytes and multi-analyte mixtures; diagnostic assay preparations for scientificindustrial and research purposes; kits comprising assays and chemical reagents for industrial and scientific research purposes; all the aforesaid goods being reference standard materials
Class 5
Pharmaceuticalveterinarymedical preparationsnamely chemical reagentsmedical diagnostic assays for testing of body fluidstissue sampleskeratinized sampleshard tissue samplesanalytesmulti-analytes and multi-analyte mixtures in the nature of diagnostic substances for medical use for pharmaceuticalveterinary and medical use; clinical diagnostic reagents for pharmaceuticalveterinary and medical use; clinical diagnostic reagent kits comprised of chemical reagents for medical usemedical diagnosticassays for testing of body fluidstissue sampleskeratinized sampleshard tissue samplesandanalytesmulti-analytes and multi-analyte mixtures in the nature of diagnostic substances for medical use for genetic diagnosis; diagnostic assay kits comprised of diagnostic agentspreparations and substances for medical diagnostic use; Substanceschemical reagents for medical usemedical diagnosticassays for testing of body fluidstissue sampleskeratinized sampleshard tissue samplesandanalytesmulti-analytes and multi-analyte mixtures in the nature of diagnostic substances for medical usefor forensic diagnostics; all the aforesaid goods being reference standard materials for use in medicalclinicalveterinary settings
Class 42
Scientific research; Quality control for others; chemical analysis; forensic analysis in the nature of research services in the field of forensic scienceanalysisdetection and isolation of biological or chemical substances in forensic samples; biological research; testing services of the goods and services of others to determine conformity with certification and quality standards; testing of chemicals; informationadvisory and consultancy services relating to all of the aforesaid; all the aforesaid relating to reference standard materials services
Publications
History of USPTO decisions and trademark events.
42 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/06/2026
FIMP
FINAL DISPOSITION PROCESSED
07/06/2026
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
05/07/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/30/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/30/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
12/30/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/11/2025
PUBO
PUBLISHED FOR OPPOSITION
11/11/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/05/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/14/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/10/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/10/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
10/10/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
10/06/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/06/2025
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
10/06/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/06/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/06/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
09/12/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/27/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
08/27/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
08/07/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/07/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
08/07/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/07/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/07/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/10/2025
GNFR
FINAL REFUSAL E-MAILED
04/10/2025
CNFR
FINAL REFUSAL WRITTEN
04/10/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/25/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/25/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/25/2025
RFNT
REFUSAL PROCESSED BY IB
09/14/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/26/2024
RFRR
REFUSAL PROCESSED BY MPU
08/26/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/20/2024
CNRT
NON-FINAL ACTION WRITTEN
08/19/2024
DOCK
ASSIGNED TO EXAMINER
08/08/2024
MAFR
APPLICATION FILING RECEIPT MAILED
04/05/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/01/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/28/2024
Continuous trademark protection
Get notified about every new filing that threatens LIPOMED or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.